Physician profile
Christopher James Lesar
NPI 1285628917
$311,360.06
in general payments reported to CMS, 2019-2025
31 companies · $32K in 2025
The $32K reported for 2025 was more than what 96% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $66K · 2021: $27K · 2022: $48K · 2023: $51K · 2024: $31K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $78K · Honoraria: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,060 · Education: $5,175 · Food and Beverage: $4,887 · Travel and Lodging: $1,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $77,745.83 |
| Honoraria | $17,281.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,060.00 |
| Education | $5,175.00 |
| Food and Beverage | $4,886.65 |
| Travel and Lodging | $1,622.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $74,454.23 | 2020-2025 | Venclose Maven Catheter, Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm |
| Terumo Medical Corporation | $72,623.09 | 2019-2025 | Navicross, Glidewire, R2p Misago |
| Cardiovascular Systems INC. | $55,512.94 | 2019-2023 | Diamondback Peripheral |
| Philips North America LLC | $55,456.69 | 2019-2025 | (9520) Igt Devices Undivided, (6554) Periph Vasc Undiv, (Bh4) Igt Devices Undivided |
| Janssen Pharmaceuticals, INC | $23,725.57 | 2019-2022 | |
| Abbott Laboratories | $15,134.01 | 2021-2025 | Diamondback Peripheral, Esprit, Jeti |
| Cordis US Corp. | $7,480.85 | 2021-2025 | Mynx Control Venous, Radianz, Precise Pro Rx |
| Asahi Intecc USA, INC. | $2,142.91 | 2020 | |
| Medtronic, INC. | $1,334.58 | 2021-2025 | Venaseal |
| Veryan Medical Incorporated | $1,040.98 | 2021-2025 | Biomimics 3d Vascular Stent System |
| Inari Medical, INC. | $715.48 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotronik INC. | $291.33 | 2022 | |
| Medtronic Vascular, INC. | $206.77 | 2019-2020 | |
| Becton, Dickinson and Company | $203.07 | 2025 | Venclose Maven Catheter |
| Smith+Nephew, INC. | $151.73 | 2019-2025 | Collagenase Santyl, Renasys Touch, Pico 14 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $132.94 | 2021 | |
| Boston Scientific Corporation | $119.75 | 2019-2021 | |
| Limflow INC. | $113.33 | 2023 | Limflow System |
| Stryker Corporation | $100.58 | 2025 | Artix Mt, Inthrill Thrombectomy Catheter, Limflow System |
| W. L. Gore & Associates, INC. | $65.17 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Getinge USA Sales, LLC | $59.16 | 2019-2020 | |
| Cook Medical LLC | $48.15 | 2021 | |
| Tactile Systems Technology INC | $47.12 | 2022-2025 | Flexitouch Plus, Nimbl |
| Reflow Medical INC | $46.33 | 2025 | |
| Merz North America, INC. | $35.68 | 2022 | |
| Cardiva Medical, INC. | $25.27 | 2024 | Cardiva Vascade 5f Vcs |
| Cvrx, INC. | $24.03 | 2025 | Barostim Neo System |
| Shockwave Medical, INC | $20.34 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $20.32 | 2019 | |
| Avinger INC. | $15.16 | 2020 | |
| Novo Nordisk INC | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lesar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.